China Approves Keytruda For Lung Cancer Treatment

Merck’s Keytruda is the first anti-PD-1 therapy to be approved as monotherapy, and in combination with chemotherapy, for lung cancer patients in China.

Merck Opens US$15 Million Lab In Singapore

The M Lab Collaboration Center will recreate actual manufacturing conditions for biologics and enhance biosafety testing.

Merck Invests €40 Million In Asia

Merck has invested an additional €40 million (US$49.35 million) to build a robust manufacturing and distribution platform in Asia over a span of two years.

Merck Granted CRISPR Patent In Singapore

Merck’s patent covers the successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR gene editing.

Merck Commits €250 Million To Drug Production In China

Merck has inaugurated its Nantong plant in Jiangsu province, its largest manufacturing plant outside of Europe.

A*STAR, MSD To Team Up On Macrocyclic Peptide Therapeutics

The two-year collaboration will focus on improving the delivery of macrocyclic peptides into cells.